121 related articles for article (PubMed ID: 9116166)
1. Transposition of the imidazole ring substituents of angiotensin mimetics related to Losartan.
Smith JR; Wahhab A; Moore D; Ganter RC; Moore GJ
Drug Des Discov; 1994 Nov; 12(2):113-9. PubMed ID: 9116166
[TBL] [Abstract][Full Text] [Related]
2. Imidazole based non-peptide angiotensin II receptor antagonists. Investigation of the effect of the orientation of the imidazole ring on biological activity.
Wahhab A; Smith JR; Ganter RC; Moore DM; Hondrelis J; Matsoukas J; Moore GJ
Arzneimittelforschung; 1993 Nov; 43(11):1157-68. PubMed ID: 8292058
[TBL] [Abstract][Full Text] [Related]
3. Diphenylpropionic acids as new AT1 selective angiotensin II antagonists.
Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; Rodríguez R; Carceller E; García-Rafanell J; Forn J
J Med Chem; 1996 May; 39(11):2197-206. PubMed ID: 8667363
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
[TBL] [Abstract][Full Text] [Related]
5. [Losartan. The first non-peptide angiotensin II receptor antagonist for treatment of hypertension].
Ibsen H; Rasmussen S; Slatanach R
Ugeskr Laeger; 1996 Jun; 158(26):3798-802. PubMed ID: 8686080
[No Abstract] [Full Text] [Related]
6. Synthesis and biological activities of non-peptide angiotensin receptor antagonists with tetrazole replaced imidazole ring.
Wahhab A; Smith J; Moore GJ
Arzneimittelforschung; 1993 Aug; 43(8):828-30. PubMed ID: 8216436
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
[TBL] [Abstract][Full Text] [Related]
8. The conformation and activity relationship of fused analogs of DuP753.
Yoo SE; Shin YA; Lee SH; Kim NJ
Bioorg Med Chem; 1995 Mar; 3(3):289-95. PubMed ID: 7606390
[TBL] [Abstract][Full Text] [Related]
9. Effect of losartan on short-term variability of blood pressure of renovascular hypertensive rats: a spectral study.
Ponchon P; Grichois ML; Elghozi JL
J Hypertens Suppl; 1993 Dec; 11(5):S244-5. PubMed ID: 8158366
[No Abstract] [Full Text] [Related]
10. Design and synthesis of nonpeptide angiotensin II receptor antagonists featuring acyclic imidazole-mimicking structural units.
Angiolini M; Belvisi L; Poma D; Salimbeni A; Sciammetta N; Scolastico C
Bioorg Med Chem; 1998 Nov; 6(11):2013-27. PubMed ID: 9881093
[TBL] [Abstract][Full Text] [Related]
11. Losartan does not influence the blood platelet aggregation in normotensive rats.
Chabielska E; Pawlak R; Buczko W
Acta Physiol Hung; 1996; 84(3):271-2. PubMed ID: 9219602
[TBL] [Abstract][Full Text] [Related]
12. A new antihypertensive class: the angiotensin receptor antagonist.
Kupecz D
Nurse Pract; 1996 Mar; 21(3):106, 109, 113-4. PubMed ID: 8710244
[No Abstract] [Full Text] [Related]
13. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
Yanagisawa H; Amemiya Y; Kanazaki T; Shimoji Y; Fujimoto K; Kitahara Y; Sada T; Mizuno M; Ikeda M; Miyamoto S; Furukawa Y; Koike H
J Med Chem; 1996 Jan; 39(1):323-38. PubMed ID: 8568823
[TBL] [Abstract][Full Text] [Related]
15. Losartan (Cozaar).
Baldinger S
Conn Med; 1996 May; 60(5):281-4. PubMed ID: 8998906
[No Abstract] [Full Text] [Related]
16. How well have animal studies with losartan predicted responses in humans?
Sweet CS; Nelson EB
J Hypertens Suppl; 1993 Apr; 11(3):S63-7. PubMed ID: 8315522
[TBL] [Abstract][Full Text] [Related]
17. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors.
Raiden S; Giordano M; Andonegui G; Trevani AS; López DH; Nahmod V; Geffner JR
J Pharmacol Exp Ther; 1997 May; 281(2):624-8. PubMed ID: 9152365
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity.
Lin HS; Rampersaud AA; Zimmerman K; Steinberg MI; Boyd DB
J Med Chem; 1992 Jul; 35(14):2658-67. PubMed ID: 1635064
[TBL] [Abstract][Full Text] [Related]
19. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
[TBL] [Abstract][Full Text] [Related]
20. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
